期刊文献+

抗中性粒细胞抗体在川崎病诊断中的价值 被引量:7

Value of anti-neutrophil cytoplasmic antibody in diagnosis of Kawasaki disease
原文传递
导出
摘要 目的探讨抗中性粒细胞抗体(ANCA)在川崎病诊断中的价值。方法检测30例典型川崎病患儿和16例不完全川崎病患儿急性期、恢复期血清ANCA,并随机选取25例健康儿童作为对照组。同时对川崎病患儿急性期行超声心动图(UCG)检查。结果川崎病患儿急性期血清ANCA阳性率为65%,其中不完全川崎病组和典型川崎病组血清ANCA阳性率分别为69%、63%,均明显高于对照组(P<0.01)。川崎病患儿恢复期血清ANCA阳性率显著低于急性期(33%vs 65%,P<0.05)。川崎病患儿急性期血清ANCA阳性率显著高于UCG的阳性检出率(P<0.01)。ANCA阳性患儿冠脉病变发生率明显高于ANCA阴性患儿(43%vs 13%,P<0.05)。结论血清ANCA可以作为一项早期诊断川崎病的参考指标和发生冠脉损害的一项实验室预警指标。[中国当代儿科杂志,2012,14(1):45-47] Objective To study the value of anti-neutrophil cytoplasmic antibody(ANCA) in diagnosis of Kawasaki disease(KD).Methods Serum ANCA was detected in 30 children with typical Kawasaki disease(TKD) and in 16 with incomplete Kawasaki disease(IKD) in the acute and the recovery phases respectively.Twenty-five healthy children were randomly selected as a control group.An ultrasonic cardiography(UCG) was performed on children with KD in the acute phase.Results The mean positive rate of serum ANCA in the acute phase in KD children was 65%,with 69% in IKD children and 63% in TKD children,which were obviously higher than that in the control group(P0.01).The positive rate of serum ANCA in the recovery phase in KD children was significantly lower than that in the acute phase(33% vs 65%,P0.05).The positive rate of serum ANCA in the acute phase in children with KD was significantly higher than that detected by UCG(P0.01).The incidence rate of coronary artery lesions in children with positive ANCA was obviously higher than that in children with negative ANCA(43% vs 13%;P0.05).Conclusions Serum ANCA may be used as a reference index for early diagnosis of KD and secondary coronary artery lesions in children.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2012年第1期45-47,共3页 Chinese Journal of Contemporary Pediatrics
关键词 川崎病 抗中性粒细胞抗体 冠脉病变 儿童 Kawasaki disease Anti-neutrophil cytoplasmic antibody Coronary artery lesion Child
  • 相关文献

参考文献14

二级参考文献87

共引文献284

同被引文献36

  • 1Guilpain P, Mouthon L. Antiendothelial cells autoantibodies in aseulitis-associated systemic diseases[J]. Clin Rev Allergy Immunol, 2008, 35(1-2): 59-65.
  • 2Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization[J]. Kidney Int, 1998, 53(3):743-753.
  • 3Japaness Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Pediatr Int, 2005, 47(6): 711-732.
  • 4Belay ED, Maddox RA, Holman RC, et al. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003[J]. Pediatr Infect Dis J, 2006, 25(3): 245-249.
  • 5Kobayashi S, Fujimoto S, Takahashi K, et al. Anti-neutrophil cytoplasmic antibody-associated vasculitis, large vessel vasculitis and Kawasaki disease in Japan[J]. Kidney Blood Press Res, 2010, 33(6): 442-455.
  • 6Kuo HC, Yu HR, Juo SH, et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwan Residents children[J]. J Hum Genet, 2011, 56(2): 161-165.
  • 7Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747-2771.
  • 8Grunebaum E, Blank M, Cohen S, et al. The role of anti- endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies[J]. Clin Exp Immunol, 2002, 130(2): 233-240.
  • 9Karasawa R, Fujieda M, Yudoh K. Detection of specific markers: our research on the marker in patients with Kawasaki disease[J]. Nihon Rinsho Meneki Gakkai Kaishi, 2010, 33(4): 207-213.
  • 10Lin YS, Lin CF, Lei HY, et al. Antibody-mediated endothelialcell damage via nitric oxide[J]. Curt Pharm Des, 2004, 10(2): 213-221.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部